Dr Reddy's Q4 Results: Net profit rises 22% YoY to ₹1,594 crore, revenue up 20%; announces dividend

Dr Reddy's Laboratories Q4FY25 results: Dr Reddy's Laboratories, the country's leading India-based pharmaceutical company, released its March quarter performance on Friday, May 9, reporting a 22% year-on-year jump in consolidated net profit to ₹1,594 crore, beating Street estimates of ₹1,491 crore.

Revenue also exceeded estimates, coming in at ₹8,506 crore compared to ₹7,083 crore in the same period last year, marking a growth of 20%.

On the operating front, EBITDA came in at ₹2,975 crore, marking a 58.9% improvement compared to ₹1,872 crore in Q4FY23, while margins expanded by 510 basis points to reach 29.1%. In the same quarter of the previous fiscal year, the company had reported a margin of 24%.

(more to come)

Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

Download the Mint app and read premium stories